Suppression of NF-kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits
about
The Effect of Diabetes Mellitus on Apoptosis in Hippocampus: Cellular and Molecular AspectsChromium picolinate and chromium histidinate protects against renal dysfunction by modulation of NF-κB pathway in high-fat diet fed and Streptozotocin-induced diabetic ratsDiabetes alters KIF1A and KIF5B motor proteins in the hippocampusDicholine succinate, the neuronal insulin sensitizer, normalizes behavior, REM sleep, hippocampal pGSK3 beta and mRNAs of NMDA receptor subunits in mouse models of depression.Diabetes and Cognitive Impairment.Oxidative stress: Biomarkers and novel therapeutic pathways.New strategies for Alzheimer's disease and cognitive impairment.Diabetes mellitus: channeling care through cellular discoveryHuperzine A ameliorates cognitive deficits in streptozotocin-induced diabetic ratsFOXO3a governs early and late apoptotic endothelial programs during elevated glucose through mitochondrial and caspase signaling.Vitamin E As a Potential Interventional Treatment for Metabolic Syndrome: Evidence from Animal and Human Studies.Wnt1, FoxO3a, and NF-kappaB oversee microglial integrity and activation during oxidant stress.Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome.Postnatal treadmill exercise alleviates short-term memory impairment by enhancing cell proliferation and suppressing apoptosis in the hippocampus of rat pups born to diabetic rats.Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases.γ-Tocotrienol but not γ-tocopherol blocks STAT3 cell signaling pathway through induction of protein-tyrosine phosphatase SHP-1 and sensitizes tumor cells to chemotherapeutic agents.The neuronal insulin sensitizer dicholine succinate reduces stress-induced depressive traits and memory deficit: possible role of insulin-like growth factor 2.Pharmacological potential of tocotrienols: a review.Novel avenues of drug discovery and biomarkers for diabetes mellitus.δ-Tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens.The effects of prenatal and early postnatal tocotrienol-rich fraction supplementation on cognitive function development in male offspring ratsTranslating cell survival and cell longevity into treatment strategies with SIRT1Association of environmental markers with childhood type 1 diabetes mellitus revealed by a long questionnaire on early life exposures and lifestyle in a case-control study.Apigenin attenuates diabetes-associated cognitive decline in rats via suppressing oxidative stress and nitric oxide synthase pathway.Effects of diabetes on hippocampal neurogenesis: links to cognition and depression.The vitamin nicotinamide: translating nutrition into clinical care.Central role of TRAF-interacting protein in a new model of brain sexual differentiation.Role of NF-kappaB in the anti-inflammatory effects of tocotrienols.Current perspectives on pharmacotherapy of Alzheimer's disease.γ-Tocotrienol suppresses growth and sensitises human colorectal tumours to capecitabine in a nude mouse xenograft model by down-regulating multiple molecules.Tocotrienol and Its Role in Chronic Diseases.Ocular Nerve Growth Factor Administration Modulates Brain-derived Neurotrophic Factor Signaling in Prefrontal Cortex of Healthy and Diabetic Rats.Brain injury with diabetes mellitus: evidence, mechanisms and treatment implications.Diabetes, adult neurogenesis and brain remodeling: New insights from rodent and zebrafish models.Whole Grains in Amelioration of Metabolic Derangements.Inflammation in Diabetic Encephalopathy is Prevented by C-Peptide.Oxymatrine attenuates diabetes-associated cognitive deficits in rats.Suppression of methylglyoxal hyperactivity by mangiferin can prevent diabetes-associated cognitive decline in rats.Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways.Activation of mTOR signaling mediates the increased expression of AChE in high glucose condition: in vitro and in vivo evidences.
P2860
Q26748541-965CC43E-F0B2-4CB8-B9A1-614DB69EAF6DQ28384183-AA5460B8-563F-4B37-93E4-80E32A3867ABQ28567468-B7A4CF07-447B-41B7-8969-7AF6E0428C64Q30621713-9F6E8DB9-E096-497E-9C47-381B50E73DC4Q31119662-5A2E7F9C-F942-47BF-8C4C-6C35F417EA0BQ33682262-4513D951-30D6-407D-A3DD-EAA9513454FBQ33717008-EAAFEDD1-09E2-47D8-829D-6FDDD5A7552EQ33749358-4B9B61B2-1E84-4A10-BD25-CA9324C1E8C1Q33755620-72874EFD-605D-40D0-A1A9-B79146569224Q33802721-363D1D17-5217-46FF-A11E-7321BE8EBA9EQ33870969-D0F893FA-0666-492C-99D2-B0E0F6937F16Q33945459-B3E25C33-9C34-4358-9582-495D93C3DE84Q34031315-601662CF-C5AF-49A9-8212-5F86B8A2C8BFQ34150343-AEC6F109-066B-4556-BAAB-CAFE084A8E61Q34209443-83666908-093B-4C5D-903E-181AF86C9699Q34236653-4DA93932-FC1F-4D6D-9A4D-49F5580EA249Q34417848-D2ED9314-34A9-4CE3-ADB4-904A0EAF5EF8Q34450166-1FB50AE0-F466-4D0B-9AC8-22EA3E0F5F60Q34552287-95CEF759-E06A-441C-B156-B314BFBB5B64Q34646385-B7C0DFF1-D0C8-4FE8-B388-07D845BB0B19Q34883598-FF20DE6C-14AF-42E4-BBDD-B8FF66D68365Q35660308-7E65009A-18C7-46EC-9C29-3447525C031BQ36147370-3F4C8850-3233-479B-898F-88437B9A7DD2Q36317556-C751DA0C-DA14-4CAA-B886-8485B0A62439Q37210037-A8BE37F4-7ACC-416B-A071-2BA29453A2E4Q37374047-013315AC-73BA-4EAB-8162-7154CBE40708Q37377326-FF62485A-7348-4BAA-A1CF-96099B9A384EQ37786156-802C0140-146C-40C9-A889-C7EACC05BDDFQ37827489-821A84B1-E662-46A2-93DB-64C862E8BEF5Q38749027-5081A35B-040A-474F-AA93-4E8B79299CB8Q38965196-4DF9FB5F-D579-4B50-A0C5-11D195A9F28AQ39043559-46E73757-5105-4E09-9512-2320DAEECE13Q39170234-13F96174-F72D-412D-9535-EB47AFB5580EQ39260245-8D43DE9E-1561-4A2D-B43A-14338280859CQ41700402-1687FD1F-3063-4C75-9934-58A43C202D64Q41819713-0666F9D7-CA15-46D4-8313-5402014CF838Q42589295-61784182-3232-492B-B43F-70FFBCA1DFEEQ43776154-B17DF9AB-AC3D-4A05-8019-60EC3FAB2DA2Q46318632-205D509F-292F-4BA3-B936-F1F636BF3ECBQ46669053-037C9F0A-480E-4B07-AE57-E39760121164
P2860
Suppression of NF-kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Suppression of NF-kappabeta si ...... associated cognitive deficits
@ast
Suppression of NF-kappabeta si ...... associated cognitive deficits
@en
Suppression of NF-kappabeta si ...... associated cognitive deficits
@nl
type
label
Suppression of NF-kappabeta si ...... associated cognitive deficits
@ast
Suppression of NF-kappabeta si ...... associated cognitive deficits
@en
Suppression of NF-kappabeta si ...... associated cognitive deficits
@nl
prefLabel
Suppression of NF-kappabeta si ...... associated cognitive deficits
@ast
Suppression of NF-kappabeta si ...... associated cognitive deficits
@en
Suppression of NF-kappabeta si ...... associated cognitive deficits
@nl
P2093
P3181
P1476
Suppression of NF-kappabeta si ...... associated cognitive deficits
@en
P2093
Anurag Kuhad
Kanwaljit Chopra
Mahendra Bishnoi
Vinod Tiwari
P3181
P356
10.1016/J.PBB.2008.12.012
P407
P577
2009-04-01T00:00:00Z